JPS6247214B2 - - Google Patents
Info
- Publication number
- JPS6247214B2 JPS6247214B2 JP55036712A JP3671280A JPS6247214B2 JP S6247214 B2 JPS6247214 B2 JP S6247214B2 JP 55036712 A JP55036712 A JP 55036712A JP 3671280 A JP3671280 A JP 3671280A JP S6247214 B2 JPS6247214 B2 JP S6247214B2
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- chitosan
- present
- solution
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001436 collagen Polymers 0.000 claims description 85
- 102000008186 Collagen Human genes 0.000 claims description 77
- 108010035532 Collagen Proteins 0.000 claims description 77
- 229920001661 Chitosan Polymers 0.000 claims description 56
- 239000000203 mixture Substances 0.000 claims description 36
- 230000002378 acidificating effect Effects 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 239000007795 chemical reaction product Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 238000011282 treatment Methods 0.000 description 26
- 238000000034 method Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 22
- 239000007864 aqueous solution Substances 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- 239000006185 dispersion Substances 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 17
- 239000000835 fiber Substances 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 238000004132 cross linking Methods 0.000 description 14
- 239000010408 film Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 235000013580 sausages Nutrition 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 238000004070 electrodeposition Methods 0.000 description 11
- 235000013372 meat Nutrition 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000010411 cooking Methods 0.000 description 7
- 235000015277 pork Nutrition 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- 230000000391 smoking effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000000908 ammonium hydroxide Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108010093096 Immobilized Enzymes Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000011941 Tilia x europaea Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- -1 cryoxal Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 229920000831 ionic polymer Polymers 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 229920002085 Dialdehyde starch Polymers 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000006990 Pimenta dioica Nutrition 0.000 description 2
- 240000008474 Pimenta dioica Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 108700040099 Xylose isomerases Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000009172 bursting Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 102000034240 fibrous proteins Human genes 0.000 description 2
- 108091005899 fibrous proteins Proteins 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 238000003505 heat denaturation Methods 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- LPZOCVVDSHQFST-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CC LPZOCVVDSHQFST-UHFFFAOYSA-N 0.000 description 1
- 241000143437 Aciculosporium take Species 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 210000001361 achilles tendon Anatomy 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000015244 frankfurter Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 235000020993 ground meat Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000012022 methylating agents Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 230000035322 succinylation Effects 0.000 description 1
- 238000010613 succinylation reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000010971 suitability test Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Processing Of Meat And Fish (AREA)
Description
本発明は、キトサン及びコラーゲンより成る組
成物に係る。更に詳しくは、耐熱性、耐吸湿性、
機械的特性等に秀れ且つ生体に対して非吸収性で
あるキトサンとコラーゲンより成る新規な組成物
に係る。
コラーゲンは、哺乳類、鳥類などの結合組織、
骨、歯、ジン帯、ケン、真皮、筋膜等に存在する
硬タンパク質であり、可食ケーシング材、外科用
縫合糸、血管移植片或いは人工皮膚等の形で広く
用いられている。コラーゲンは上記の如き応用分
野で用いられている他の材料に比べ優れている
が、必ずしも満足すべきものと言い難い。
例えば、ハム、ソーセージ等の燻煙処理を必要
とする食品ケーシング材として、可食性であり且
つ水中での強伸度が大きいとの理由から、牛、
豚、羊等の食用動物の腸、即ち天然のコラーゲン
成形体が用いられている。しかしながら、該天然
のコラーゲン成形体は、生産量に制限を有し、ま
た繁雑な処理工程を経て製造されるためコストの
高いものである。しかも、該天然のコラーゲン成
形体は、形状、品質が不揃い故にハム、ソーセー
ジ等の製造において通常の高速肉詰め機に適用さ
れ難い。
上記欠点を解消するものとして、後述の如き方
法等によつて得られるコラーゲン繊維のチユーブ
状物、即ち人工のコラーゲンケーシングが提案さ
れている。しかしながら、該人工のコラーゲン繊
維は成膜性に劣る。また該人工のコラーゲンケー
シングは、機械的強度の問題から膜厚が厚く、こ
の為外観の見劣りや食感性を著しく損う欠点を有
する。更に、該人工のコラーゲンケーシングより
なるハム、ソーセージ等は加熱調理時に破損した
り、また充填された肉とケーシング間で剥離する
等の好ましくない現象を生起する。最近、該調理
時での問題を解消するものとして、人工のコラー
ゲンケーシングを更に架橋化処理する方法も提案
されている。しかしながら、該架橋化コラーゲン
ケーシングでは食感性の点で満足し難い。
一方、前述の外科用縫合糸、人工皮膚或いは止
血用材等の外科的医療材料としてのコラーゲン材
料は、強度的問題の他に生体安定性(非吸収性)
の点で不満を残す。該コラーゲン材料の生体安定
性を発現せしめる方法は種々検討されている。例
えば、コラーゲンを架橋化する方法がある。しか
しながら、該方法によつて得られる成形材は引張
り強度及び伸度等の機械的性質が著しく低下した
ものになる。また、下記の如き反応式で表わされ
るコラーゲンとカルボキシル基或いはスルフエー
ト基を有する高分子物質とのポリイオンコンプレ
ツクスの形成により解決する方法も試みられてい
る。
H3N−−COO+Y−COO又はY−
SO3
→Y−COOH3N−−COO又は
Y−SO3H3N−−COO
(式中、H3N−−COOはコラーゲンを、
Y−COO又はY−SO3は高分子物質を示
す。)
得られるポリイオンプレツクスは生体安定性に
すぐれ且つ抗血栓性を有する。しかしながら、該
ポリイオンコンプレツクスは水性媒体、例えば塩
化ナトリウム溶液の如き無機塩溶液に溶解し、ま
た機械的特性に劣る。従つて、該ポリイオンコン
プレツクスにさらに架橋化処理等の安定化処理を
施す必要がある。
本発明者等は、上記実情に鑑み、広範囲に及ぶ
用途に適する新しい組成物の開発について鋭意研
究していく過程において、キトサンとコラーゲン
とを接触せしめてなるキトサン−コラーゲン組成
物が極めて合目的であることを知見し、本発明に
到達したものである。
即ち、上記知見に基く本発明はキトサンとコラ
ーゲンとを酸性領域中で接触せしめ、次いで該接
触反応物を脱酸処理し、脱溶媒し、更に必要に応
じ架橋化処理してなるキトサン/コラーゲン構成
比0.01/99.99〜99/1(重量比)の組成物を提
供するものである。
本発明の組成物は、前述塩水溶液に溶解せず、
また機械的強度、血液凝固性、耐熱性、耐菌性、
耐水性、成膜性及び肉等の充填物との密着性に優
れる。従つて、本発明の組成物は種々の用途に適
用可能である。
該用途の1つとして可食ケーシング材を挙げる
ことができる。また、桐山等(A.N.INo.71)が報
告している様にキトサンは下記a〜dの如き生理
活性を有するので、
a 血漿コレステロールの正常化
b 血糖抑制
c 成長阻害物質の除去
d 大腸ガンの防止
本発明の組成物は、球状、繊維状物として食品
中に添加使用され得、食用材料として上記諸症状
に対し予防的または治療的効果を挙げることがで
きる。
更に、本発明の組成物は、キトサンの生体に対
する非吸収性とコラーゲンの血液凝固作用を併有
する故、フイルム状、繊維状或いはその他三次元
構造の形態で医療及び外科的応用に供せられ得
る。本発明のキトサン−コラーゲン組成物は、そ
れ自体血栓性であるが、ヘパリン処理することに
より、抗血栓性材料として用いられ得、人工血
管、人工皮膚、人工腎臓等の医療材料として利用
され得る。
又、本発明の組成物は、蛋白質吸着能に優れる
故、酵素、微生物等の微生物固定化基材或いは吸
着剤としても利用できる。
本発明の組成物が前述の如き優れた機械的特
性、非吸収性及び血液凝固作用を有する等々の理
由については未だ明らかでないが、下記の如き反
応によるキトサン及びコラーゲン由来のアミノ基
に基因するもの推察される。
H3N−−COO+Z−NH3〓→ H3N−
−COOH3N−Z
(式中、 H3N−−COOはコラーゲン
を、 〓H3N−Zはキトサンを示す。)
以下、本発明を詳述する。
本発明に係るキトサンは、溶解性及び作業性の
点から脱N−アセチル化度50〜100%、好ましく
は70〜100%、粘度20〜1000cpを有するものであ
る。該キトサンは、市販のものでも良く、又カ
ニ、エビ等の節足動物の甲殻から常法によつて分
離・精製して得られるキチンを高濃度のアルカリ
水溶液中で加熱処理することによつても入手し得
る。なお、上記粘度は0.5wt%溶液(溶媒:1wt
%酢酸水溶液)中20℃で測定されたものである。
本発明に係るコラーゲンは、脊椎動物及び無脊
椎動物の結合組織中の主要な蛋白質である繊維成
分から化学的および機械的処理により非コラーゲ
ン性の組織成分を分離したものである。該コラー
ゲンは、例えば、以下の方法で製造され得る。即
ち、脱毛処理した牛皮、牛アキレス腱を肉挽機等
で細断後酸性或いはアルカリ性の媒体中で膨潤さ
せ、次いで擂潰機等で解繊し、水性分散液とし、
更に必要に応じ過分離する。
本発明で用いるコラーゲンは、繊維径1〜3
μ、繊維長0.1〜15mm、分子量5000〜1000000好ま
しくは20000〜500000であるが、必ずしもこれに
限定されるものでない。例えば、該コラーゲンを
機械処理等により細繊維化し、或いは酵素処理に
よりテロペプチドの一部又は全部を切断して可溶
性のコラーゲンとして用いてもよい。又、それら
の混合物も使用できる。この場合、コラーゲン繊
維100重量部に対して可溶化コラーゲン40重量部
以下が機械的強度から好ましい。しかしながら、
用途によつては必ずしもこれに限定されない。ま
た、人工又は天然コラーゲンケーシングの屑等そ
のままでは使用出来ない廃物をあげることができ
る。なお、上記製造における細断工程後、細断片
を前処理することは得られる組成物の強度の向上
及び均質化にとつて好ましい。該前処理としては
コラーゲンのリジン残基中のアミノ基をホルムア
ルデヒド、グルタールアルデヒド、ジアルデヒド
スターチ、クリオキザール、燻液或いはエピハロ
ヒドリン等の試薬による架橋化、コハク酸無水物
によるサクシニル化、無水有機酸によるアシル化
或いはメチル化剤を用いてのコラーゲン中のアス
パラギン酸、グルタミン酸等の側鎖にあるカルボ
ン酸のエステル化等を例示できる。
本発明の組成物は、前記したキトサンとコラー
ゲンとを酸性領域中で接触せしめ、次いで、該接
触反応物を脱酸処理し、脱溶媒し、更に必要に応
じて架橋化処理することにより得ることができ
る。なお、ここで言う酸性領域とはキトサン−コ
ラーゲンの接触系内がPH1〜6好ましくは3〜6
であることを意味する。
前記脱酸処理とは、キトサン−コラーゲンの接
触反応物の等電点以上にPHを調整することであ
る。従つて、該脱酸処理は、接触反応系内を水酸
化ナトリウム、水酸化カリウム等のアルカリで処
理し、PH7以上とするか、或いは接触反応物中に
過剰に存在する酸を蒸発除去する方法、電着法に
より電解脱酸する方法を提示できる。
本発明の製法によれば、従来成形性において不
満を残したコラーゲンをキトサンと複合させるこ
とにより成形性(成膜性など)を向上することが
でき、尚かつ製造時の歩止りおよび製品の安定
性、画一性等の問題を解決し得る。又、コラーゲ
ンを前処理として架橋化処理した際の遊離のアル
デヒド基とも反応することになるので、安全性の
問題からも好ましいことである。
以下、本発明の組成物より成る成形体(以下、
本発明の成形体と称する)の製造例を述べる。
その1つとして、キトサン含有酸性媒体とコラ
ーゲン含有媒体とを混合分散する方法を例示でき
る。この場合、キトサン含有酸性媒体中のキトサ
ン濃度は5wt%好ましくは1wt%以下(溶媒:酢
酸、塩酸等の稀薄水溶液)であり、該キトサン含
有酸性媒体のPHは1〜6好ましくは3〜6であ
る。コラーゲン含有媒体は、コラーゲンを塩酸等
の酸性水溶液に分散し、PHを3〜6好ましくは3
〜4に調整したものである。コラーゲン含有媒体
は必ずしも酸性である必要はなく、アルカリ性で
あつてもよい。しかしながら、この場合、キトサ
ン含有酸性媒体と混合分散した際、混合分散系は
酸性領域にあることが必要である。該コラーゲン
含有媒体のコラーゲン含有量は任意で良いが、粘
度等の関係から通常5wt%以下、好ましくは1wt
%以下である。キトサン含有酸性媒体とコラーゲ
ン含有媒体との混合割合は、目的とする組成物の
キトサン/コラーゲン構成比0.01/99.99〜99/
1(重量比)の範囲で適宜選ぶことができる。
本発明において、フイルム状の成形体は、上記
所定の割合の混合液を脱泡処理後、該混合液をガ
ラス板上に流し込み、更に熱風乾燥機等で脱酸処
理し、次いで脱溶媒する方法で製造し得る。本発
明に係るフイルム状の成形体は繊維性蛋白質を1
構成成分とするにもかかわらず、強度面で縦横の
方向依存性のないことを特徴とする。該特徴はキ
トサンが存在することによりはじめて発現し得る
ものであり、この事実は全く驚くべきことと言え
る。また、球状の成形体は、前記混合液をトルエ
ン、キシレン等の疎水性の有機溶媒中に滴下・分
散させ、次いでアルコール−水系溶液で脱酸処理
し、次いで脱溶媒する方法で製造できる。更に、
上記混合液をホール或いはスリツト状のノズルか
ら高濃度の塩又は水酸化アンモニウム等のアルカ
リ水溶液中に押し出すことで繊維状、フイルム状
或いはフイルム状中空状の形態として成形するこ
ともできる。なお、本発明のキトサンを含有する
蛋白質分散水溶液を少なくとも1個の陰極及び少
なくとも1個の陽極を備えた電極槽に導入し、上
記両電極間に直流電圧を加え、所定電極面上に集
積せしめる場合、本発明の成形体を極めて速く成
形し得る。前記電着法により得られる本発明のチ
ユーブ状成形体は、極めて薄い壁膜となり、電着
時及び湿潤状態で強度的にも優れ且つ食感性の良
い可食ケーシング材として好適である。
本発明の組成物をフイルム状中空体として可食
ケーシング材に用いる場合、食感性、燻煙及び調
理時の強度、熱変性温度、ヒートシール性の観点
からキトサン/コラーゲンの構成比が0.01/
99.99〜60/40の範囲が好ましい。又、可食性食
品添加剤として用いる場合は0.01/99.99〜99/
1の範囲で良く、食用材料としてキトサン成分の
多い方が好ましい。
別の製造法として、キトサン含有酸性媒体中に
予めシート、フイルム、チユーブ、繊維状等に成
形したコラーゲン成形体を浸漬し、次いで脱酸処
理し、脱溶媒する方法も例示できる。この場合、
得られる成形体は表面部がキトサン成分故機械的
性質の向上、耐熱性、耐菌性等の極めてユニーク
な性質を示すものである。しかしながら、浸漬法
で得られる成形体より、コラーゲン−キトサンの
混合溶液から得られる成形体の方が強度的にすぐ
れる。
上記方法等によつて得られる本発明の成形体
は、更に架橋化や、無水物によるサクシニル化、
無水有機酸によるアシル化或いはメチル化剤を用
いてのコラーゲン中のアスパラギン酸、グルタミ
ン酸等の側鎖にあるカルボン酸のエステル化処理
することにより、上記特性の他に高血液凝固性、
耐酸性の向上が発現される。
架橋化は例えば以下の方法によつて行うことが
できる。
まず本発明の成形体を、PH7.4のリン酸緩衝液
に架橋剤を溶解した水溶液中に浸漬する。該浸漬
は10〜50℃の温度下0.1〜1時間行う。反応終了
後、洗浄工程を経れば水に不溶な架橋化処理され
た成形体となる。
該架橋化処理により、キトサンの架橋化のみな
らず、キトサン−コラーゲンの架橋化も生起し得
るので、より表面結合力が上昇する。架橋は、例
えば、キトサンおよびコラーゲンのアミノ基およ
び水酸基の同種又は異種官能基の間で生起する。
架橋剤としては、ホルムアルデヒド、グルタール
アルデヒド、ジアルデヒドスターチ、グリオキザ
ール、燻液或いはエピハロヒドリン等があげられ
る。又、エチレングリコール、グリセリン、ソル
ビトール等の多価アルコール及び糖類も用いられ
る。
尚、電着法による本発明のフイルム状中空体で
ある成形体の製造において、前述分散水溶液中に
上記架橋剤を添加分散せしめ、電着時に架橋化処
理する方法も例示できる。
本発明に係る繊維性蛋白質としては蚕の糸中の
フイブロイン、毛中のケラチン、血液中のフイブ
リノーゲン等をあげることができる。
以上、本発明は自然界に多量に存在するが、高
結晶性且つ化学的に安定故、その利用分野が限定
されていたキチンとコラーゲンとを組合わせるこ
とで両者の欠点をおぎなかつて余りある特性を有
する新規な組成物を提供するもので、その産業上
の貢献は大と言える。
以下、実施例をもつて本発明を説明する。
実施例 1
北米産ステアハイド塩蔵皮100Kgを15時間水
漬、水洗後、裏取機により、脂肪をけづり取つ
た。次いで該裏取りされた皮を石灰浸漬処理し
た。石灰浸漬処理は、消石灰2%、Na2S0.5%
(C2H5)2NH20.5%を含む液450Kgに上記の皮90Kg
を入れ、25℃にて24時間ゆるやかに撹拌する方法
によつた。該処理後の皮は脱毛ロールにかけ脱毛
するとともに石灰浸漬処理によつて生じた分解物
を取り除いた。次いで該処理皮をスプリツテイン
グ機により分割し、ミイートスライサーにより幅
5mmに切り、更に肉挽機により長さ5cmに細片に
した。この細片80Kgを水800Kg中に分散させ、更
に酢酸3Kgを入れ、ゆるやかに12時間撹拌後この
分散液から該皮細片を分離し、遠心脱水機により
脱水し、イオン交換水で洗浄した。洗浄は洗浄水
の電気伝導度が20μ/cm以下になつた時点で終
了せしめた。この時点における皮中の灰分は0.1
%以下であつた。
この皮細片40Kgを0.015%濃度のグルタールア
ルデヒドを含み、塩酸によりPH3.0に調整した水
溶液400Kgに分散させ、20℃で12時間ゆるやかに
撹拌して架橋化処理した。
次いで該処理皮を金網で分離し、パルプリフア
イナーを用いて冷水113Kg中で繊維束を叨解し、
コラーゲン繊維の分散液とし、更に塩酸を加えて
PH3.0に調節した。この分散液は太さ1〜3μ、
長さ1〜10mmのコラーゲン繊維と更に細繊化した
コラーゲンの混合物となり、2.5%コラーゲンを
含む液125Kgとなつた。
一方、キトサン1KgをPH3の塩酸水溶液10Kgに
溶解後、PHを3.0に調整し、総重量20Kgのキトサ
ン溶液を得た。
前記架橋コラーゲン分散液1.5Kgにイオン交換
水50Kgを加え、急速にに撹拌し、次いでこの分散
液にキトサン水溶液374gを加え、1時間撹拌混
合し、コラーゲン/キトサンの重量比が100/5
である混合溶液を得た。この混合溶液は粘度
200cp、電気伝導度250μ/cmであつた。
次に該混合液から電着装置を用いて製膜した。
該電着装置は、内径100m/mφ、高さ700m/m
のPVC製の穴明き円筒で支持された白金網を陽
極とし、その内部へ外径17.5m/mφ、長さ700
m/mのステンレス製管の陰極を有し、その極間
に内径56m/m、厚み1m/mPVC製隔膜ホル
ダーにプロピレン繊維製布をはつて極間を仕切
つたものであつた。
陽極槽内はPH3.0の塩酸水溶液を槽下部より流
入し、槽上部よりオーバーフローし、陽極液ホル
ダーへ落ち、再び槽下からポンプにより循環せし
めておいた。膜原料物は陰極槽下部より導入し、
上部よりオーバーフローせしめ、該混合液貯蔵槽
へ戻る様にしておいた。陽極槽のオーバーフロー
部は陰極槽のオーバーフロー面より50mm低くし、
隔膜から塩酸水溶液が陰極槽へ流入しない様にし
ておいた。温度は10℃以下に保つた。
該電着装置に前記キトサン/コラーゲン混合液
を入れ、循環させ、電極間へ直流電圧300Vをか
けた。正に帯電しているコラーゲン−キトサンは
電気泳動により陰極へ移動し、水の電解によつて
生じたOH-により中和され、等電点のPHに近づ
き、水和水を放出し、凝集し、陰極面上に膜を形
成した。
膜引き上げ速度は10m/minとした。
この電着直後のチユーブ状物は含水量2g−
H2O/g、引張り強度200Kg/cm2であつた。
引き上げられた膜は7%グリセリン水溶液へ浸
した後空気で水柱300m/mの圧力を保ちながら
75℃の熱風で2分間乾燥し、本発明のチユーブ状
成形体(試料A)を得た。
比較の為、キトサンを添加しないコラーゲン分
散液を用いて同様な方法で比較コラーゲン膜(比
較試料A)を得た。尚、比較試料Aの電着直後の
チユーブ含水量7g−H2O/g、引張り強度100
Kg/cm2であつた。
該成形体をJIS P−8113,JIS P−8116に準じ
て湿潤状態で引張り強度及び引裂強度を測定した
結果を第1表に示した。これより明らかな様にキ
トサンを添加したものについては引張り強度が著
しくあがり、尚かつ極めて薄い膜が得られた。
又、これらの成形体を0.2N−塩化ナトリウム
水溶液に20℃24時間浸漬した後、上記方法にのつ
とり強度を調べた結果を第2表に示した。この結
果、本発明の成形体は強度的にも優れており、単
なるイオン結合でコラーゲンと結合しているだけ
でなく、バインダー的要素も含んでいることが明
らかとなつた。
The present invention relates to a composition comprising chitosan and collagen. More specifically, heat resistance, moisture absorption resistance,
The present invention relates to a novel composition consisting of chitosan and collagen that has excellent mechanical properties and is non-absorbable to living bodies. Collagen is the connective tissue of mammals, birds, etc.
It is a hard protein that exists in bones, teeth, skin, dermis, fascia, etc., and is widely used in the form of edible casing materials, surgical sutures, vascular grafts, artificial skin, etc. Although collagen is superior to other materials used in the above applications, it is not always satisfactory. For example, beef, beef,
The intestines of food animals such as pigs and sheep, that is, natural collagen molded bodies, are used. However, the natural collagen molded body has a limited production amount and is manufactured through complicated processing steps, resulting in high cost. Moreover, the natural collagen molded bodies are not uniform in shape and quality, and therefore are difficult to be applied to ordinary high-speed meat stuffing machines in the production of hams, sausages, and the like. To overcome the above-mentioned drawbacks, a tube-shaped collagen fiber, ie, an artificial collagen casing, obtained by a method as described below has been proposed. However, the artificial collagen fibers have poor film-forming properties. Furthermore, the artificial collagen casing has a thick film thickness due to mechanical strength problems, and therefore has disadvantages such as poor appearance and significantly impaired texture. Furthermore, hams, sausages, etc. made of the artificial collagen casings are damaged during cooking, and undesirable phenomena such as separation between the filled meat and the casing occur. Recently, a method of further crosslinking the artificial collagen casing has been proposed to solve the problem during cooking. However, the crosslinked collagen casing is difficult to satisfy in terms of texture. On the other hand, collagen materials used as surgical medical materials such as surgical sutures, artificial skin, and hemostatic materials mentioned above have not only strength problems but also biostability (non-absorbability).
I am dissatisfied with this point. Various methods have been studied to improve the biostability of the collagen material. For example, there is a method of crosslinking collagen. However, the molded material obtained by this method has significantly reduced mechanical properties such as tensile strength and elongation. In addition, a method of solving the problem by forming a polyion complex between collagen and a polymeric substance having a carboxyl group or a sulfate group has also been attempted, which is represented by the following reaction formula. H 3 N−−COO+Y−COO or Y−
SO 3 →Y−COOH 3 N−−COO or Y−SO 3 H 3 N−−COO (in the formula, H 3 N−−COO represents collagen,
Y-COO or Y-SO 3 represents a polymer substance. ) The resulting polyionplex has excellent biostability and antithrombotic properties. However, the polyionic complexes are soluble in aqueous media, such as inorganic salt solutions such as sodium chloride solutions, and have poor mechanical properties. Therefore, it is necessary to further perform stabilization treatment such as crosslinking treatment on the polyion complex. In view of the above circumstances, the present inventors, in the process of conducting intensive research into the development of new compositions suitable for a wide range of uses, found that a chitosan-collagen composition made by bringing chitosan and collagen into contact was extremely suitable. This discovery led to the present invention. That is, the present invention, based on the above findings, provides a chitosan/collagen structure obtained by bringing chitosan and collagen into contact in an acidic region, then deoxidizing the contact reaction product, removing solvent, and further crosslinking if necessary. A composition having a ratio of 0.01/99.99 to 99/1 (weight ratio) is provided. The composition of the present invention does not dissolve in the aqueous salt solution,
In addition, mechanical strength, blood coagulation, heat resistance, bacterial resistance,
Excellent water resistance, film formability, and adhesion to fillers such as meat. Therefore, the composition of the present invention is applicable to various uses. One such use is as an edible casing material. In addition, as reported by Kiriyama et al. (ANI No. 71), chitosan has the following physiological activities a) Normalization of plasma cholesterol b Suppression of blood sugar c Removal of growth-inhibiting substances d Prevention of colorectal cancer The composition of the present invention can be added to foods in the form of spherical or fibrous materials, and can exert preventive or therapeutic effects on the above-mentioned symptoms as an edible material. Furthermore, since the composition of the present invention has both the non-absorbability of chitosan to the living body and the blood coagulation effect of collagen, it can be used in medical and surgical applications in the form of a film, fiber, or other three-dimensional structure. . Although the chitosan-collagen composition of the present invention is thrombogenic in itself, it can be used as an antithrombotic material by treatment with heparin, and can be used as medical materials such as artificial blood vessels, artificial skin, and artificial kidneys. Furthermore, since the composition of the present invention has excellent protein adsorption ability, it can also be used as a substrate for immobilizing microorganisms such as enzymes and microorganisms, or as an adsorbent. The reason why the composition of the present invention has the above-mentioned excellent mechanical properties, non-absorbability, and blood coagulation effect is not yet clear, but it is due to the amino groups derived from chitosan and collagen produced by the following reaction. It is inferred. H 3 N−−COO+Z−NH 3 〓→ H 3 N−
-COOH 3 N-Z (In the formula, H 3 N--COO represents collagen, and H 3 N-Z represents chitosan.) The present invention will be described in detail below. The chitosan according to the present invention has a degree of de-N-acetylation of 50 to 100%, preferably 70 to 100%, and a viscosity of 20 to 1000 cp from the viewpoint of solubility and workability. The chitosan may be commercially available, or it may be obtained by heat-treating chitin obtained by separating and purifying it from the shells of arthropods such as crabs and shrimps by conventional methods in a highly concentrated alkaline aqueous solution. can also be obtained. In addition, the above viscosity is 0.5wt% solution (solvent: 1wt
% acetic acid aqueous solution) at 20°C. The collagen according to the present invention is obtained by separating non-collagenous tissue components from the fibrous components, which are the main proteins in connective tissues of vertebrates and invertebrates, by chemical and mechanical treatments. The collagen can be produced, for example, by the following method. That is, depilated cowhide and beef Achilles tendon are shredded using a meat grinder or the like, then swollen in an acidic or alkaline medium, and then defibrated using a grinder or the like to form an aqueous dispersion.
Further, over-separate as necessary. The collagen used in the present invention has a fiber diameter of 1 to 3.
μ, fiber length 0.1-15 mm, molecular weight 5,000-1,000,000, preferably 20,000-500,000, but are not necessarily limited to these. For example, the collagen may be made into fine fibers by mechanical treatment or the like, or part or all of the telopeptide may be cleaved by enzyme treatment and used as soluble collagen. Also, mixtures thereof can be used. In this case, from the viewpoint of mechanical strength, it is preferable that the solubilized collagen be 40 parts by weight or less per 100 parts by weight of collagen fibers. however,
Depending on the application, it is not necessarily limited to this. In addition, waste materials that cannot be used as they are, such as scraps of artificial or natural collagen casings, can be cited. In addition, after the shredding step in the above production, it is preferable to pre-treat the fragments in order to improve the strength and homogenize the resulting composition. The pretreatment includes crosslinking amino groups in lysine residues of collagen with reagents such as formaldehyde, glutaraldehyde, dialdehyde starch, cryoxal, liquid smoke, or epihalohydrin, succinylation with succinic anhydride, and organic acid anhydride. Examples include esterification of carboxylic acids in side chains such as aspartic acid and glutamic acid in collagen using an acylating or methylating agent. The composition of the present invention can be obtained by bringing the above-described chitosan and collagen into contact in an acidic region, then deacidifying the contact reaction product, removing the solvent, and further subjecting it to crosslinking treatment if necessary. Can be done. Note that the acidic region referred to here means that the chitosan-collagen contact system has a pH of 1 to 6, preferably 3 to 6.
It means that. The deoxidizing treatment is to adjust the pH to a level higher than the isoelectric point of the chitosan-collagen contact reaction product. Therefore, the deacidification treatment is a method in which the inside of the contact reaction system is treated with an alkali such as sodium hydroxide or potassium hydroxide to raise the pH to 7 or higher, or a method in which the excess acid present in the contact reaction product is removed by evaporation. , we can present a method of electrolytic deoxidation using electrodeposition method. According to the manufacturing method of the present invention, by combining collagen with chitosan, which has been unsatisfactory in moldability in the past, it is possible to improve moldability (film formability, etc.), and also to improve yield during manufacturing and stabilize products. Problems such as gender and uniformity can be solved. Furthermore, since it also reacts with free aldehyde groups obtained when collagen is crosslinked as a pretreatment, this is preferable from a safety standpoint. Hereinafter, a molded article (hereinafter referred to as
An example of manufacturing a molded article (referred to as a molded article of the present invention) will be described. One example is a method of mixing and dispersing a chitosan-containing acidic medium and a collagen-containing medium. In this case, the chitosan concentration in the chitosan-containing acidic medium is 5wt%, preferably 1wt% or less (solvent: dilute aqueous solution of acetic acid, hydrochloric acid, etc.), and the pH of the chitosan-containing acidic medium is 1 to 6, preferably 3 to 6. be. The collagen-containing medium is prepared by dispersing collagen in an acidic aqueous solution such as hydrochloric acid, and adjusting the pH to 3 to 6, preferably 3.
It was adjusted to ~4. The collagen-containing medium does not necessarily have to be acidic; it can also be alkaline. However, in this case, when mixed and dispersed with the chitosan-containing acidic medium, the mixed dispersion system needs to be in an acidic region. The collagen content of the collagen-containing medium may be arbitrary, but it is usually 5wt% or less, preferably 1wt% due to viscosity etc.
% or less. The mixing ratio of the chitosan-containing acidic medium and the collagen-containing medium is such that the chitosan/collagen composition ratio of the target composition is 0.01/99.99-99/
It can be appropriately selected within the range of 1 (weight ratio). In the present invention, the film-like molded product is obtained by degassing the mixture at the predetermined ratio, pouring the mixture onto a glass plate, deoxidizing it using a hot air dryer, etc., and then removing the solvent. It can be manufactured in The film-like molded article according to the present invention contains 1 fibrous protein.
Although it is a constituent component, it is characterized by having no vertical and horizontal direction dependence in terms of strength. This characteristic can only be expressed in the presence of chitosan, and this fact can be said to be completely surprising. Moreover, a spherical molded body can be produced by dropping and dispersing the liquid mixture in a hydrophobic organic solvent such as toluene or xylene, followed by deacidification treatment with an alcohol-water solution, and then desolvation. Furthermore,
By extruding the above-mentioned liquid mixture through a hole or slit-shaped nozzle into a highly concentrated salt or alkaline aqueous solution such as ammonium hydroxide, it can be formed into a fibrous, film-like, or hollow film-like form. In addition, a protein dispersion aqueous solution containing the chitosan of the present invention is introduced into an electrode bath equipped with at least one cathode and at least one anode, and a DC voltage is applied between the two electrodes to cause it to accumulate on a predetermined electrode surface. In this case, the molded article of the present invention can be molded extremely quickly. The tube-shaped molded product of the present invention obtained by the electrodeposition method has an extremely thin wall, and is suitable as an edible casing material that has excellent strength and good texture during electrodeposition and in a wet state. When the composition of the present invention is used as a film-like hollow body for an edible casing material, the composition ratio of chitosan/collagen is 0.01/1 from the viewpoint of texture, strength during smoking and cooking, heat denaturation temperature, and heat sealability.
A range of 99.99 to 60/40 is preferred. Also, when used as an edible food additive, 0.01/99.99-99/
It may be within the range of 1, and as an edible material, it is preferable to have a large amount of chitosan component. Another example of a manufacturing method is a method in which a collagen molded object previously formed into a sheet, film, tube, fiber, etc. is immersed in an acidic medium containing chitosan, followed by deacidification treatment and solvent removal. in this case,
The resulting molded product exhibits extremely unique properties such as improved mechanical properties, heat resistance, and antibacterial properties due to the chitosan component on the surface. However, a molded article obtained from a mixed solution of collagen and chitosan is superior in strength to a molded article obtained by the dipping method. The molded article of the present invention obtained by the above method etc. can be further crosslinked, succinylated with anhydride, etc.
In addition to the above properties, high blood coagulability, high blood coagulability,
Improved acid resistance is exhibited. Crosslinking can be carried out, for example, by the following method. First, the molded article of the present invention is immersed in an aqueous solution in which a crosslinking agent is dissolved in a phosphate buffer solution having a pH of 7.4. The immersion is carried out at a temperature of 10 to 50°C for 0.1 to 1 hour. After the reaction is completed, a washing step is performed to obtain a water-insoluble crosslinked molded product. The crosslinking treatment can cause not only chitosan crosslinking but also chitosan-collagen crosslinking, thereby further increasing surface bonding strength. Crosslinking occurs, for example, between the same or different functional groups of amino and hydroxyl groups of chitosan and collagen.
Examples of the crosslinking agent include formaldehyde, glutaraldehyde, dialdehyde starch, glyoxal, liquid smoke, and epihalohydrin. Polyhydric alcohols and sugars such as ethylene glycol, glycerin, and sorbitol are also used. In the production of the film-like hollow body of the present invention by electrodeposition, an example of a method is to add and disperse the crosslinking agent in the aqueous dispersion solution and carry out crosslinking treatment during electrodeposition. Examples of the fibrous protein according to the present invention include fibroin in silkworm silk, keratin in hair, and fibrinogen in blood. As described above, the present invention has a characteristic that overcomes the drawbacks of chitin and collagen, which exist in large amounts in nature but whose fields of application are limited due to their high crystallinity and chemical stability. The present invention provides a novel composition having the following characteristics, and its contribution to industry can be said to be significant. The present invention will be explained below with reference to Examples. Example 1 100 kg of salted stearhide skin from North America was soaked in water for 15 hours, washed with water, and then the fat was scraped off using a lining machine. The lined skin was then subjected to a lime soak treatment. Lime immersion treatment uses slaked lime 2%, Na 2 S 0.5%
Add 90 kg of the above skin to 450 kg of liquid containing 0.5% (C 2 H 5 ) 2 NH 2
was added and gently stirred at 25°C for 24 hours. After the treatment, the skin was depilated using a depilation roll and decomposed products produced by the lime immersion treatment were removed. The treated skin was then divided into pieces using a splitting machine, cut into 5 mm wide pieces using a meat slicer, and further cut into 5 cm long pieces using a meat grinder. 80 kg of the skin pieces were dispersed in 800 kg of water, and 3 kg of acetic acid was added thereto, and after gentle stirring for 12 hours, the skin pieces were separated from the dispersion, dehydrated using a centrifugal dehydrator, and washed with ion-exchanged water. The washing was terminated when the electrical conductivity of the washing water became 20 μ/cm or less. The ash content in the skin at this point is 0.1
% or less. 40 kg of this skin strip was dispersed in 400 kg of an aqueous solution containing glutaraldehyde at a concentration of 0.015% and adjusted to pH 3.0 with hydrochloric acid, and was gently stirred at 20° C. for 12 hours to undergo crosslinking treatment. Next, the treated skin was separated using a wire mesh, and the fiber bundle was dissolved in 113 kg of cold water using a pulp refiner.
Make a dispersion of collagen fibers and add hydrochloric acid to it.
Adjusted to PH3.0. This dispersion has a thickness of 1 to 3μ,
A mixture of collagen fibers with a length of 1 to 10 mm and further finely divided collagen was obtained, resulting in 125 kg of liquid containing 2.5% collagen. On the other hand, 1 kg of chitosan was dissolved in 10 kg of an aqueous hydrochloric acid solution with a pH of 3, and the pH was adjusted to 3.0 to obtain a chitosan solution with a total weight of 20 kg. 50 kg of ion-exchanged water was added to 1.5 kg of the crosslinked collagen dispersion and stirred rapidly. Then, 374 g of chitosan aqueous solution was added to this dispersion and stirred and mixed for 1 hour until the weight ratio of collagen/chitosan was 100/5.
A mixed solution was obtained. This mixed solution has a viscosity of
It had an electrical conductivity of 200 cp and an electrical conductivity of 250 μ/cm. Next, a film was formed from the mixed solution using an electrodeposition device.
The electrodeposition device has an inner diameter of 100m/mφ and a height of 700m/m.
A platinum wire mesh supported by a PVC cylinder with holes is used as an anode, and a wire with an outer diameter of 17.5 m/mφ and a length of 700 mm is inserted into the anode.
It had a stainless steel tube cathode measuring m/m, and a propylene fiber cloth was attached to a PVC diaphragm holder with an inner diameter of 56 m/m and a thickness of 1 m/m to partition the electrodes. In the anode tank, an aqueous hydrochloric acid solution with a pH of 3.0 was introduced from the bottom of the tank, overflowed from the top of the tank, fell into the anolyte holder, and was circulated again from the bottom of the tank by a pump. The membrane raw material is introduced from the bottom of the cathode tank,
The mixture was allowed to overflow from the top and returned to the mixed liquid storage tank. The overflow part of the anode tank should be 50mm lower than the overflow surface of the cathode tank.
The aqueous hydrochloric acid solution was prevented from flowing into the cathode tank from the diaphragm. The temperature was kept below 10℃. The chitosan/collagen mixture was placed in the electrodeposition device, circulated, and a DC voltage of 300 V was applied between the electrodes. The positively charged collagen-chitosan moves to the cathode by electrophoresis, is neutralized by OH - generated by water electrolysis, approaches the isoelectric point PH, releases hydration water, and aggregates. , a film was formed on the cathode surface. The membrane pulling speed was 10 m/min. This tube-like material immediately after electrodeposition has a water content of 2 g-
H 2 O/g and tensile strength of 200 Kg/cm 2 . The pulled membrane was immersed in a 7% glycerin aqueous solution and then heated with air while maintaining a water column pressure of 300 m/m.
It was dried with hot air at 75° C. for 2 minutes to obtain a tube-shaped molded article (sample A) of the present invention. For comparison, a comparative collagen membrane (comparative sample A) was obtained in the same manner using a collagen dispersion to which chitosan was not added. In addition, the tube moisture content of comparative sample A immediately after electrodeposition was 7 g-H 2 O/g, and the tensile strength was 100.
It was Kg/ cm2 . Table 1 shows the results of measuring the tensile strength and tear strength of the molded product in a wet state according to JIS P-8113 and JIS P-8116. As is clear from this, the tensile strength was significantly increased with the addition of chitosan, and an extremely thin film was obtained. Table 2 shows the results of immersing these molded bodies in a 0.2N aqueous sodium chloride solution at 20°C for 24 hours, and then examining the detent strength using the above method. As a result, it was revealed that the molded article of the present invention has excellent strength and is not only bound to collagen through simple ionic bonds, but also contains a binder-like element.
【表】【table】
【表】
実施例 2
実施例1におけるキトサン−コラーゲン混合液
の割合をコラーゲン100重量部に対してキトサン
20部にし、膜引き上げ速度を25m/minとした以
外は、同一条件下で成膜し、連続的なフイルム状
物である本発明の成形体(試料B)を得た。
尚、比較の為に同様に膜引き上げ速度でコラー
ゲン単独分散液(0.58wt%)についても行なつた
が、連続的に引き上げる事は出来なかつた。
本発明の成形体の機械的特性は、膜厚8μ、引
張り強度510Kg/cm2、引裂強度32g・cm/cm、伸
度32%であつた。
実施例 3
実施例1で得た2.5%コラーゲン分散液10Kgと
5%キトサン水溶液1.5Kgを撹拌混合後これを真
空脱泡処理した。これを0.1N水酸化アンモニウ
ム水溶液を入れた凝固溶中に巾10cm、間隔0.3mm
のスリツトより押し出し、水洗後実施例1と同様
の後処理を行い、フイルム状の本発明の成形体
(試料C)を得た。
該フイルム状物は実施例1と同様に測定した結
果、膜厚30μ、引張り強度520Kg/cm2、引裂強度
75g・cm/cm、伸度30%であつた。
尚、キトサンを添加せずに同一条件で成形した
フイルム(比較試料B)は、膜厚30μ、引張り強
度200Kg/cm2、引裂強度48g・cm/cm、伸度26%
であつた。
以上の結果から本発明の成形体は強度的に秀れ
ていることが明らかになつた。
実施例 4
機械充填適性テスト
実施例2で得たチユーブ状の試料Bと実施例1
で得た比較試料Aをソーセージケーシングとして
使つた時の実用試験を行つた。
肉エマルジヨンはフランクフルトもしくはウイ
ンナータイプの混合物でその組成は下記の割合と
した。
豚の塩漬肉 1300g
豚の背脂肪 750g
卵 白 90g
氷 水 750g
でん粉 120g
グルタミン酸ソーダ 9g
オールスパイス 12g
砂 糖 9g
リン酸 6g
コシヨー 6g
エマルジヨンの製造は通常用いられる食肉用の
装置により次の工程で製造した。
1 豚肉の塩漬
豚肉を3cm角に切り、食塩を塗付し、良く混
合後15℃で12時間塩漬けする。
2 豚脂身は肉挽機(2φの穴)で2回挽き、4
℃にて12時間冷却した。
3 塩漬豚肉も同様に肉挽機にて2回挽き、4℃
に冷却する。
4 挽肉1300gをサイレントカツターに入れ、水
400gを加え、低速で混和しながら卵白90gを
加えた。
5 次に肉挽機で挽き、4℃に冷却してある豚脂
身750gに水350gを入れ、混和しながらでん粉
120gを加えた。
6 最後に調味料としてグルタミン酸ソーダ9
g、コシヨー6g、オールスパイス12g、砂糖
9g及びリン酸塩6gを加え、高速で混和し
た。
この様にして得られた混合物を半自動スタツフ
アーワーカー760により二種類のケーシングに詰
めたときの充填テストの結果を第3表に示した。
第3表から明らかな様にキトサン添加物は苛酷
な充填テストにも耐えうる。尚、本発明のケーシ
ングは、ソーセージの結び目は細く、外観的にも
秀れたものであつた。[Table] Example 2 The ratio of the chitosan-collagen mixture in Example 1 to 100 parts by weight of collagen was
The film was formed under the same conditions, except that the volume was 20 parts and the film pulling speed was 25 m/min, to obtain a continuous film-like molded article of the present invention (sample B). For comparison, a dispersion of collagen alone (0.58 wt%) was also tested at the same membrane pulling speed, but it was not possible to pull it up continuously. The mechanical properties of the molded article of the present invention were a film thickness of 8 μm, a tensile strength of 510 Kg/cm 2 , a tear strength of 32 g·cm/cm, and an elongation of 32%. Example 3 After stirring and mixing 10 kg of the 2.5% collagen dispersion obtained in Example 1 and 1.5 kg of the 5% chitosan aqueous solution, the mixture was subjected to vacuum defoaming treatment. This was placed in a coagulation solution containing 0.1N ammonium hydroxide aqueous solution with a width of 10cm and a spacing of 0.3mm.
It was extruded through a slit, washed with water, and then subjected to the same post-treatment as in Example 1 to obtain a film-shaped molded article of the present invention (sample C). The film-like material was measured in the same manner as in Example 1 and found to have a thickness of 30μ, a tensile strength of 520Kg/cm 2 , and a tear strength.
It had a weight of 75 g·cm/cm and an elongation of 30%. In addition, the film (comparative sample B) molded under the same conditions without adding chitosan had a film thickness of 30 μ, a tensile strength of 200 Kg/cm 2 , a tear strength of 48 g cm/cm, and an elongation of 26%.
It was hot. From the above results, it is clear that the molded article of the present invention has excellent strength. Example 4 Mechanical filling suitability test Tube-shaped sample B obtained in Example 2 and Example 1
A practical test was conducted using Comparative Sample A obtained in Example 1 as a sausage casing. The meat emulsion was a frankfurter or wiener type mixture whose composition was as follows. Salted pork 1300g Pork back fat 750g Egg white 90g Ice water 750g Starch 120g Sodium glutamate 9g Allspice 12g Sugar 9g Phosphoric acid 6g Koshiyo 6g The emulsion is manufactured using the following process using commonly used meat equipment. did. 1 Salting pork Cut the pork into 3cm cubes, coat with salt, mix well, and salt for 12 hours at 15℃. 2 Grind the pork fat twice in a meat grinder (2φ hole),
Cooled at ℃ for 12 hours. 3 Grind the salted pork twice in a meat grinder and bring it to 4℃.
Cool to 4 Put 1300g of ground meat into a silent cutter and add water.
Added 400g and added 90g of egg white while mixing at low speed. 5 Next, add 350g of water to 750g of pork fat that has been ground in a meat grinder and cooled to 4℃, and add starch while mixing.
Added 120g. 6 Finally, add sodium glutamate 9 as a seasoning.
g, 6 g of koshiyo, 12 g of allspice, 9 g of sugar, and 6 g of phosphate were added and mixed at high speed. Table 3 shows the results of a filling test when the mixture thus obtained was packed into two types of casings using a semi-automatic stuffer worker 760. As is clear from Table 3, the chitosan additive can withstand severe filling tests. The casing of the present invention had a thin sausage knot and was excellent in appearance.
【表】
実施例 5
実施例4で得られたソーセージ試料No.2,No.8
を燻煙処理した。
該処理は棒に8個の輪で鎖状につるし、燻煙室
に入れ、初め55〜60℃にコントロールし、30分間
乾燥後、75℃に上昇させ、木材チツプから発生さ
せた煙を導入し、更にスチームを導入して燻煙室
の湿度を一定にし、30分間処理した。
該処理が終了後スチームを導入し、燻煙室内の
温度を75〜80℃に50分間処理後、燻煙室より取り
出し、冷水を噴霧し、急冷却した。
該処理したソーセージを家庭の主婦が調理する
ことを想定し、調理時の破裂性のテストを行つ
た。
・ フライテスト
温度調節器付のフライ鍋に油(商品名 日清テ
ンプラ油)を入れて160℃に保ち、各サンプル10
個のソーセージを用意し、油温の低下を防止する
為一度に2個のソーセージを入れ、ケーシングが
30秒間に破裂する量を測定した。
・ フライパンテスト
フライパンの表面の温度を均一に保つ為オイル
バスへフライパンの底部を浸し、オイル面下10mm
に位置する様に固定し、フライパンの表面が175
〜180℃になるようにオイルバスの温度をコント
ロールした。フライパンに前述テンプラ油を少量
入れて全面に塗付し、各サンプル10個のソーセー
ジを用意し、5個づつに分けて入れ、ゆつくり動
かし、2分間にケーシングが破裂する量を測定し
た。これを同一サンプルについて2回繰返した。
・ ボイルテスト
湯鍋(深さ50mm)を用意し、沸騰状態に保ち、
各サンプルについて10個のソーセージを用意し、
5個づつに分けて湯鍋に入れ、5分間ボイルした
時の破裂した量を測定した。これを同一サンプル
について2回繰返した。
これらの結果を第4表に示した。
第4表から明らかな様に実用的な調理テストに
おいても極めて優れていた。[Table] Example 5 Sausage samples No. 2 and No. 8 obtained in Example 4
was smoked. In this process, the wood chips are hung in a chain with 8 rings on a stick, placed in a smoking chamber, initially controlled at 55-60℃, dried for 30 minutes, raised to 75℃, and smoke generated from wood chips is introduced. Then, steam was introduced to keep the humidity in the smoking room constant, and the process was continued for 30 minutes. After the treatment was completed, steam was introduced and the temperature in the smoking chamber was maintained at 75 to 80° C. for 50 minutes, after which the chamber was taken out and cooled down by spraying with cold water. Assuming that the processed sausage would be cooked by a housewife at home, a test for bursting property during cooking was conducted.・Fry test Pour oil (product name: Nissin Tempura Oil) into a frying pan with a temperature controller, maintain it at 160℃, and test 10 samples of each.
Prepare 2 sausages, add 2 sausages at a time to prevent the oil temperature from dropping, and make sure the casing is
The amount that bursts in 30 seconds was measured.・ Frying pan test To keep the temperature of the surface of the frying pan uniform, dip the bottom of the frying pan into an oil bath, 10mm below the oil surface.
Fix it so that the surface of the frying pan is 175
The temperature of the oil bath was controlled to ~180°C. A small amount of the above-mentioned tempura oil was placed in a frying pan and spread over the entire surface, 10 sausages were prepared for each sample, and the sausages were placed in groups of 5 and gently moved, and the amount of casing bursting in 2 minutes was measured. This was repeated twice for the same sample.・ Boil test Prepare a hot water pot (depth 50mm) and keep it in boiling state.
Prepare 10 sausages for each sample,
They were divided into 5 pieces and placed in a hot water pot and boiled for 5 minutes, and the amount that burst was measured. This was repeated twice for the same sample. These results are shown in Table 4. As is clear from Table 4, it was also extremely excellent in practical cooking tests.
【表】
これらの事実を裏付ける方法として、これらの
充填される前の膜を75℃の熱水中に1分間浸漬
し、収縮率および熱変性温度を調べた結果を第5
表に示した。[Table] As a method to support these facts, the membranes before being filled were immersed in hot water at 75℃ for 1 minute, and the shrinkage rate and heat denaturation temperature were examined.
Shown in the table.
【表】
尚、キトサン添加されたケーシングを用いたソ
ーセージはまろやかな旨味と甘さが口中にひろが
り、食感においては類のないものであつた。これ
はコラーゲン繊維のみのケーシングを用いたソー
セージには発現しない現象であつた。
実施例 6
キトサン20gを5%酢酸水溶液1に溶解して
均一溶液とし、これをA液とする。
実施例1における架橋処理のない2.5%コラー
ゲン分散液50gをとり、酸性プロテアーゼ(長瀬
産業製)1gを加え、37℃で5時間処理した後中
和遠心分離、水洗等の操作を行ない、1N−塩酸
水溶液でPH3.5に調節し、総量1Kgとし、ホモゲ
ナイザーで10℃以下に保ちながら更に細分化し、
B液を得た。
該B液にA液を加え、ホモゲナイザーで均一溶
液とした。
別に一方にはデカリン2とポリオキシエチレ
ンソルビート(商品名ツイン#80)1gを入れた
撹拌機付き3のフラスコを準備した。
フラスコに該A−B混合液100c.c.を添加し、
1000rpmで撹拌分散させる。1時間分散後、それ
らの分散液を10のエタノール中に再分散させる
と不溶物が得られた。過、エタノール洗浄を繰
返し、有機溶媒を除いた後2%水酸化アンモニウ
ム水溶液1に再分散させ、中和後過水洗し、
凍結乾燥すると球状の本発明の成形体(試料D)
が得られた。尚、試料Dの大きさは直径0.1〜1.0
m/mであつた。
試料D1gをとり、生理食塩水に入れた後過
し、余分な食塩水を除去した。これを内径8m/
mφのガラス製のカラムに充填し、続いてヘパリ
ン250単位添加したウサギ血液50mlを20ml/min
の速度で37℃15分間潅流した。循環を停止したの
ちすみやかに血液を除去し、生理食塩水で洗浄し
た後その球状成形体を取り出し、該成形体表面の
血小板及び血球の付着程度を測定した結果、血小
板、血球とも明らかに付着が認められた。
実施例 7
1%の酢酸水溶液1に5gのキトサンを添加
して均一溶液をつくつた。(この時の溶液粘度は
50cpsであつた。)この溶液に比較試料Aのコラ
ーゲン繊維のみからなる成形体を20℃1時間浸漬
した後、余分な水溶液を除去し、湿潤状態のまま
で0.1N−アンモニア水に浸漬した後水洗して酢
酸アンモニウム、アンモニアを除去し、脱溶媒し
て、本発明の成形体(試料E)を得た。
この成形体の機械的強度は引張り強度395Kg/
cm2、引裂強度50g・cm/cm、伸度33%であつた。
尚、含浸量はコラーゲン繊維100重量部に対して
キトサン2重量部であつた。
実施例 8
実施例1において遠心脱水機により脱水した皮
細片50Kgを100の無水酢酸中に液温15℃で8時
間浸漬し、アセチル化反応させた。
該処理皮をイオン交換水の流水下で洗浄した。
尚、原料である牛皮の等電点がPH6.5であつた
が、該処理する事によりPH3.8に変化した。該処
理皮は実施例1と同様にコラーゲン繊維の分散液
とし、塩酸によりPH3.0に調節し、膨潤させ、2.5
%のコラーゲン分散液をつくつた。
これに実施例1と同様に、キトサン水溶液を加
えコラーゲン/キトサンの重量比が100/10にな
る様に調節し、実施例1の電着装置を用いて成膜
後後処理した。
それを実施例1にもとづき機械的特性を調べた
ところ、膜厚9μ、引張り強度485Kg/cm2、引裂
強度35g・cm/cm、伸度33%であつた。
実施例 9
実施例3のコラーゲン−キトサン混合溶液を
200m/m×200m/mのプレートに厚さ5m/m
で流し込み一時間静置した後、0.1N−水酸化ア
ンモニウム水溶液に浸漬し、酸を中和後イオン交
換水で洗浄し、塩類を除去した。これを0.5%の
ホルムアルデヒドを含む0.1モル第二リン酸ナト
リウム水溶液に30℃で1時間浸漬処理し、次いで
水洗した。
該処理成形体を凍結乾燥し、スポンジ状の本発
明の成形体を得た。該成形体は生理食塩水に対す
る吸収能は20g/g成形体であり、尚かつ、血液
に対する凝固性が強いので生理用品及び緊急用止
血帯として使用可能であることが判つた。
実施例 10
0.1モル第二リン酸ナトリウム水溶液500c.c.にグ
ルコースイソメラーゼ(長瀬産業製2000U/g)
1gを溶解し、実施例6におけるコラーゲン−キ
トサンの球状成形体を30g加え、5℃で2時間撹
拌後、25%グルタールアルデヒド水溶液2c.c.を更
に加え、5時間処理した。該処理後、PH7.0のリ
ン酸緩衝液で洗浄し、該処理成形体を2gのグル
コースを含むPH7.0のリン酸緩衝液500c.c.に加え、
70℃で60分間処理した後のグルコース、フラクト
ースの量を測定したところ、それぞれ600mg、
1400mgであり、固定化された酵素は70%であつ
た。
又、実施例6における分散前のコラーゲン−キ
トサン水溶液をPH6.0に調節後、上記グルコース
イソメラーゼ1gを5℃で加え、実施例6と同様
に分散後エタノールで洗浄し、PH7.0リン酸緩衝
液で洗浄した後上記方法により固定化された酵素
の活性を調べたところ、85%であつた。
これらの結果から固定化酵素及び菌体の担体と
して使用可能であることが判る。
実施例 11
実施例2で得た試料B10gにエピクロルヒドリ
ン2gと水100c.c.を加え、1時間加熱還流後、8N
−水酸化ナトリウム水溶液100gを更に加えて油
浴上で120℃2時間加熱処理した。該架橋処理物
を水洗し、本発明の成形体を得た。該処理物は
酸、アルカリ及び有機溶媒に不溶であつた。尚、
機械的特性は実施例1と同様に測定すると引張強
度630Kg/cm2、伸度15%であつた。
実施例 12
実施例1においてコラーゲン/キトサンの重量
比を100/1100/0.1になる様にキトサンの添加量
を変えて実施例1と同一条件下でチユーブ状の成
形体(試料F,G)を得た。
これを実施例4の試料No.2の条件下で、充填し
実施例5の燻煙処理を行なつた。
尚、充填時の破裂はいすれの試料についても認
められなかつた。次に、実施例5と同様の調理テ
ストを行ない、これらの結果を第6表に示した。
第6表から明らかな様に実用的な調理テストに
おいても極めれて優れていた。[Table] In addition, the sausage using the chitosan-added casing had a mellow flavor and sweetness that spread throughout the mouth, and had an unparalleled texture. This phenomenon did not occur in sausages using a casing made only of collagen fibers. Example 6 20 g of chitosan was dissolved in 5% acetic acid aqueous solution 1 to make a homogeneous solution, and this was designated as Solution A. Take 50 g of the 2.5% collagen dispersion without crosslinking treatment in Example 1, add 1 g of acidic protease (manufactured by Nagase Sangyo), treat it at 37°C for 5 hours, and then perform operations such as neutralization centrifugation and washing with water to obtain 1N- Adjust the pH to 3.5 with an aqueous hydrochloric acid solution, bring the total amount to 1 kg, and further subdivide using a homogenizer while keeping the temperature below 10°C.
A solution B was obtained. Solution A was added to solution B, and a homogenized solution was obtained using a homogenizer. Separately, a 3-size flask equipped with a stirrer was prepared in which 2 decalin and 1 g of polyoxyethylene sorbitol (trade name Twin #80) were placed. Add 100 c.c. of the A-B mixture to the flask,
Stir and disperse at 1000 rpm. After dispersing for 1 hour, the dispersions were redispersed in 10 ml of ethanol to obtain insoluble matter. After repeating filtration and ethanol washing to remove the organic solvent, it was redispersed in 2% ammonium hydroxide aqueous solution 1, neutralized, and washed with ethanol.
Molded article of the present invention that becomes spherical when freeze-dried (Sample D)
was gotten. In addition, the size of sample D is 0.1 to 1.0 in diameter.
It was m/m. 1 g of sample D was taken, poured into physiological saline, filtered, and excess saline was removed. This has an inner diameter of 8m/
Fill a mφ glass column, then add 50 ml of rabbit blood to which 250 units of heparin was added at 20 ml/min.
perfusion for 15 minutes at 37°C. After stopping the circulation, the blood was immediately removed, the spherical molded body was taken out after washing with physiological saline, and the degree of adhesion of platelets and blood cells to the surface of the molded body was measured. As a result, it was found that neither platelets nor blood cells were clearly attached. Admitted. Example 7 5 g of chitosan was added to 1% aqueous acetic acid solution to create a homogeneous solution. (The solution viscosity at this time is
It was hot at 50cps. ) A molded article consisting only of collagen fibers of Comparative Sample A was immersed in this solution at 20°C for 1 hour, excess aqueous solution was removed, and the product was immersed in 0.1N ammonia water in a wet state, then washed with water to remove ammonium acetate. , ammonia was removed and the solvent was removed to obtain a molded article (sample E) of the present invention. The mechanical strength of this molded body is tensile strength 395Kg/
cm 2 , tear strength 50 g·cm/cm, and elongation 33%.
The amount of impregnation was 2 parts by weight of chitosan per 100 parts by weight of collagen fibers. Example 8 50 kg of skin pieces dehydrated using a centrifugal dehydrator in Example 1 were immersed in 100% acetic anhydride at a liquid temperature of 15° C. for 8 hours to cause an acetylation reaction. The treated skin was washed under running ion-exchanged water.
The isoelectric point of the raw material, cowhide, was PH6.5, but it changed to PH3.8 after this treatment. The treated skin was made into a dispersion of collagen fibers in the same manner as in Example 1, adjusted to pH 3.0 with hydrochloric acid, and swollen to 2.5
% collagen dispersion was prepared. As in Example 1, an aqueous chitosan solution was added to adjust the weight ratio of collagen/chitosan to 100/10, and the film was formed using the electrodeposition apparatus of Example 1 and then subjected to post-treatment. When its mechanical properties were examined based on Example 1, the film thickness was 9μ, tensile strength was 485Kg/cm 2 , tear strength was 35g·cm/cm, and elongation was 33%. Example 9 The collagen-chitosan mixed solution of Example 3
200m/m x 200m/m plate with a thickness of 5m/m
After pouring it in and leaving it for one hour, it was immersed in a 0.1N ammonium hydroxide aqueous solution to neutralize the acid, and then washed with ion-exchanged water to remove salts. This was immersed in a 0.1 molar dibasic sodium phosphate aqueous solution containing 0.5% formaldehyde at 30°C for 1 hour, and then washed with water. The treated molded product was freeze-dried to obtain a sponge-like molded product of the present invention. It was found that the molded product had an absorption capacity of 20 g/g for physiological saline and had strong coagulability against blood, so it could be used as a sanitary product and an emergency tourniquet. Example 10 Glucose isomerase (2000 U/g manufactured by Nagase Sangyo) in 500 c.c. of 0.1 molar dibasic sodium phosphate aqueous solution
1 g of collagen-chitosan was dissolved, and 30 g of the collagen-chitosan spherical molded article in Example 6 was added thereto. After stirring at 5° C. for 2 hours, 2 c.c. of a 25% glutaraldehyde aqueous solution was further added and treated for 5 hours. After the treatment, the treated molded body was washed with a phosphate buffer of PH 7.0, and the treated molded body was added to 500 c.c. of a phosphate buffer of PH 7.0 containing 2 g of glucose.
When the amounts of glucose and fructose were measured after being treated at 70℃ for 60 minutes, they were 600 mg and 600 mg, respectively.
1400 mg, and the immobilized enzyme was 70%. Further, after adjusting the collagen-chitosan aqueous solution before dispersion in Example 6 to pH 6.0, 1 g of the above glucose isomerase was added at 5°C, and after dispersion in the same manner as in Example 6, it was washed with ethanol, and the pH was 7.0 phosphate buffered. After washing with a solution, the activity of the immobilized enzyme was examined by the above method and found to be 85%. These results indicate that it can be used as a carrier for immobilized enzymes and bacterial cells. Example 11 2 g of epichlorohydrin and 100 c.c. of water were added to 10 g of sample B obtained in Example 2, and after heating under reflux for 1 hour, 8N
- 100 g of aqueous sodium hydroxide solution was further added and heat treated on an oil bath at 120°C for 2 hours. The crosslinked product was washed with water to obtain a molded article of the present invention. The treated product was insoluble in acids, alkalis and organic solvents. still,
Mechanical properties were measured in the same manner as in Example 1 and found to be a tensile strength of 630 Kg/cm 2 and an elongation of 15%. Example 12 Tubular shaped bodies (Samples F and G) were produced under the same conditions as in Example 1, except that the amount of chitosan added was changed so that the collagen/chitosan weight ratio was 100/1100/0.1. Obtained. This was filled under the conditions of Sample No. 2 of Example 4 and subjected to the smoking treatment of Example 5. Incidentally, no rupture was observed in any of the samples during filling. Next, a cooking test similar to that in Example 5 was conducted, and the results are shown in Table 6. As is clear from Table 6, it was also extremely excellent in practical cooking tests.
Claims (1)
99.99〜1重量%から成るキトサン−コラーゲン
組成物。 2 酸性領域中でキトサンとコラーゲンとを接触
せしめ、次いで該接触反応物を脱酸処理し、脱溶
媒することからなるキトサン−コラーゲン組成物
の製造法。 3 前記酸性領域のPHが1〜6、好ましくは3〜
6である特許請求の範囲第2項に記載の製造法。 4 キトサンとコラーゲンとを重量比で0.01:
99.99〜99:1の割合で接触せしめることを特徴
とする特許請求の範囲第2項に記載の製造法。 5 キトサン含有酸性媒体とコラーゲン含有媒体
とを混合分散することにより前記接触を行うこと
を特徴とする特許請求の範囲第2項ないしは第4
項に記載の製造法。 6 キトサン含有酸性媒体中にコラーゲン成形体
を浸漬することにより前記接触を行うことを特徴
とする特許請求の範囲第2項ないしは第4項に記
載の製造法。[Claims] 1. Chitosan 0.01-99% by weight and collagen
Chitosan-collagen composition consisting of 99.99-1% by weight. 2. A method for producing a chitosan-collagen composition, which comprises bringing chitosan and collagen into contact in an acidic region, and then deacidifying and removing the solvent from the contact reaction product. 3 The pH of the acidic region is 1 to 6, preferably 3 to 6.
6. The manufacturing method according to claim 2. 4 Chitosan and collagen weight ratio: 0.01:
The manufacturing method according to claim 2, characterized in that the contact is carried out at a ratio of 99.99 to 99:1. 5. Claims 2 to 4, characterized in that the contact is carried out by mixing and dispersing the chitosan-containing acidic medium and the collagen-containing medium.
Manufacturing method described in Section. 6. The manufacturing method according to claim 2 or 4, wherein the contact is performed by immersing the collagen molded body in an acidic medium containing chitosan.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3671280A JPS56133344A (en) | 1980-03-21 | 1980-03-21 | Novel composite material |
| US06/242,419 US4378017A (en) | 1980-03-21 | 1981-03-11 | Composite material of de-N-acetylated chitin and fibrous collagen |
| CA000373335A CA1147507A (en) | 1980-03-21 | 1981-03-18 | Composite material of de-n-acetylated chitin and fibrous collagen |
| AU68521/81A AU535551B2 (en) | 1980-03-21 | 1981-03-18 | Composite material of de-n-acetylated chitin and fibrous collagen |
| EP81301212A EP0038628B1 (en) | 1980-03-21 | 1981-03-20 | Composite material of de-n-acetylated chitin and fibrous collagen, its production and use |
| DE8181301212T DE3171293D1 (en) | 1980-03-21 | 1981-03-20 | Composite material of de-n-acetylated chitin and fibrous collagen, its production and use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3671280A JPS56133344A (en) | 1980-03-21 | 1980-03-21 | Novel composite material |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56133344A JPS56133344A (en) | 1981-10-19 |
| JPS6247214B2 true JPS6247214B2 (en) | 1987-10-07 |
Family
ID=12477367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3671280A Granted JPS56133344A (en) | 1980-03-21 | 1980-03-21 | Novel composite material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS56133344A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7376410B2 (en) | 1998-10-21 | 2008-05-20 | Parkervision, Inc. | Methods and systems for down-converting a signal using a complementary transistor structure |
| US7386292B2 (en) | 2000-04-14 | 2008-06-10 | Parkervision, Inc. | Apparatus, system, and method for down-converting and up-converting electromagnetic signals |
| US7433910B2 (en) | 2000-11-14 | 2008-10-07 | Parkervision, Inc. | Method and apparatus for the parallel correlator and applications thereof |
| US7454453B2 (en) | 2000-11-14 | 2008-11-18 | Parkervision, Inc. | Methods, systems, and computer program products for parallel correlation and applications thereof |
| US7460584B2 (en) | 2002-07-18 | 2008-12-02 | Parkervision, Inc. | Networking methods and systems |
| US7483686B2 (en) | 1999-03-03 | 2009-01-27 | Parkervision, Inc. | Universal platform module and methods and apparatuses relating thereto enabled by universal frequency translation technology |
| US7529522B2 (en) | 1998-10-21 | 2009-05-05 | Parkervision, Inc. | Apparatus and method for communicating an input signal in polar representation |
| US7539474B2 (en) | 1999-04-16 | 2009-05-26 | Parkervision, Inc. | DC offset, re-radiation, and I/Q solutions using universal frequency translation technology |
| US7546096B2 (en) | 1999-08-23 | 2009-06-09 | Parkervision, Inc. | Frequency up-conversion using a harmonic generation and extraction module |
| US7554508B2 (en) | 2000-06-09 | 2009-06-30 | Parker Vision, Inc. | Phased array antenna applications on universal frequency translation |
| US7599421B2 (en) | 1999-03-15 | 2009-10-06 | Parkervision, Inc. | Spread spectrum applications of universal frequency translation |
| US7620378B2 (en) | 1998-10-21 | 2009-11-17 | Parkervision, Inc. | Method and system for frequency up-conversion with modulation embodiments |
| JP2012001859A (en) * | 2010-06-18 | 2012-01-05 | Tokyo Institute Of Technology | Collagen-chitosan conjugated fiber-like porous body and method for producing the same |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62238209A (en) * | 1986-04-08 | 1987-10-19 | Nippon Bio Kemikaruzu Kk | Production of spongy material for cosmetic |
| JPH01303151A (en) * | 1988-06-01 | 1989-12-07 | Katakura Chitsukarin Kk | Artificial skin and wound covering material and production thereof |
| JPH01303152A (en) * | 1988-06-01 | 1989-12-07 | Katakura Chitsukarin Kk | Hematostatic and production thereof |
| US5858350A (en) | 1993-12-01 | 1999-01-12 | Marine Polymer Technologies | Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system |
| DE10338110A1 (en) * | 2003-08-15 | 2005-03-10 | Biomet Deutschland Gmbh | Chitosan-coated metallic article and method of making the same |
| AU2008219065B2 (en) | 2007-02-19 | 2014-01-30 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
| BR112012025844A2 (en) | 2010-04-15 | 2017-07-18 | Marine Polymer Tech Inc | use of snag nanofibers |
| CA2832859C (en) | 2011-04-15 | 2020-06-16 | Marine Polymer Technologies, Inc. | Treatment of disease with poly-n-acetylglucosamine nanofibers |
| RU2509091C1 (en) * | 2012-07-05 | 2014-03-10 | Федеральное государственное бюджетное учреждение науки Институт высокомолекулярных соединений Российской академии наук | Biocompatible, biodegradable composite fibre and method for production thereof |
-
1980
- 1980-03-21 JP JP3671280A patent/JPS56133344A/en active Granted
Non-Patent Citations (1)
| Title |
|---|
| CEOCHIMICAET COSMOCHIMICA ACTA=1978 * |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7620378B2 (en) | 1998-10-21 | 2009-11-17 | Parkervision, Inc. | Method and system for frequency up-conversion with modulation embodiments |
| US7389100B2 (en) | 1998-10-21 | 2008-06-17 | Parkervision, Inc. | Method and circuit for down-converting a signal |
| US7376410B2 (en) | 1998-10-21 | 2008-05-20 | Parkervision, Inc. | Methods and systems for down-converting a signal using a complementary transistor structure |
| US7529522B2 (en) | 1998-10-21 | 2009-05-05 | Parkervision, Inc. | Apparatus and method for communicating an input signal in polar representation |
| US7483686B2 (en) | 1999-03-03 | 2009-01-27 | Parkervision, Inc. | Universal platform module and methods and apparatuses relating thereto enabled by universal frequency translation technology |
| US7599421B2 (en) | 1999-03-15 | 2009-10-06 | Parkervision, Inc. | Spread spectrum applications of universal frequency translation |
| US7539474B2 (en) | 1999-04-16 | 2009-05-26 | Parkervision, Inc. | DC offset, re-radiation, and I/Q solutions using universal frequency translation technology |
| US7546096B2 (en) | 1999-08-23 | 2009-06-09 | Parkervision, Inc. | Frequency up-conversion using a harmonic generation and extraction module |
| US7496342B2 (en) | 2000-04-14 | 2009-02-24 | Parkervision, Inc. | Down-converting electromagnetic signals, including controlled discharge of capacitors |
| US7386292B2 (en) | 2000-04-14 | 2008-06-10 | Parkervision, Inc. | Apparatus, system, and method for down-converting and up-converting electromagnetic signals |
| US7554508B2 (en) | 2000-06-09 | 2009-06-30 | Parker Vision, Inc. | Phased array antenna applications on universal frequency translation |
| US7454453B2 (en) | 2000-11-14 | 2008-11-18 | Parkervision, Inc. | Methods, systems, and computer program products for parallel correlation and applications thereof |
| US7433910B2 (en) | 2000-11-14 | 2008-10-07 | Parkervision, Inc. | Method and apparatus for the parallel correlator and applications thereof |
| US7460584B2 (en) | 2002-07-18 | 2008-12-02 | Parkervision, Inc. | Networking methods and systems |
| JP2012001859A (en) * | 2010-06-18 | 2012-01-05 | Tokyo Institute Of Technology | Collagen-chitosan conjugated fiber-like porous body and method for producing the same |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56133344A (en) | 1981-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0038628B1 (en) | Composite material of de-n-acetylated chitin and fibrous collagen, its production and use | |
| JPS6247214B2 (en) | ||
| SU912032A3 (en) | Process for producing protein food fiber | |
| US9504262B2 (en) | Collagen concentrate, use thereof and also process for production thereof | |
| AU636544B1 (en) | Water insoluble biocompatible hyaluronic acid polyion complex and method of making the same | |
| US3556969A (en) | Method and apparatus for obtaining electrodeposited shaped articles from fibrous protein fibrils | |
| US3123482A (en) | R lieberman | |
| EP0070940B1 (en) | Collagen article and its production | |
| US5695800A (en) | Method of preparing a food product encased in a glucomannan film | |
| JPS6247213B2 (en) | ||
| WO1988002991A1 (en) | Edible matter and method of producing the same | |
| EP0083126B1 (en) | A process of preparing shaped products starting from dispersions containing a coagulable amphoteric high molecular substance | |
| GB1571561A (en) | Dispersion of collagen fibres | |
| JPS6146565B2 (en) | ||
| JP2561949B2 (en) | Method for producing fish wing-like food | |
| JP3197236B2 (en) | Collagen blend | |
| CN117180489B (en) | A microfiber collagen hemostatic material and its preparation method and application | |
| FI77678C (en) | FOERFARANDE FOER FRAMSTAELLNING AV EN FORMAD PRODUKT AV KOLLAGEN GENOM SYNERESIS. | |
| US3433864A (en) | Methods of extruding collagen | |
| JP2654183B2 (en) | Collagen composition, collagen composition molded article, and collagen composition coated product | |
| JP3948623B2 (en) | Gelatin-coated alginate fiber and method for producing the same | |
| US2813034A (en) | Method of producing synthetic sausage skins and products produced thereby | |
| JP3408870B2 (en) | Collagen containing egg protein and method for producing the same | |
| JPH02195860A (en) | Ham-sausages and production thereof | |
| JP3012697B2 (en) | Method for producing food having collagen film |